Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment

By afschroeder • October 6, 2025

Fava A, Wagner CA, Guthridge CJ, Macwana S, DeJager W, Munroe ME, Izmirly P, Belmont HM, Diamond B, Davidson A, Utz PJ, Weisman MH, Carlucci PM, Dall'Era M, Kalunian K, Putterman C, Anolik J, Barnas JL, Wofsy D, Kamen D, Furie RA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network; Petri M, Guthridge JM, Buyon J, James JA. Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment. Arthritis Care Res (Hoboken). 2025 Oct 6. doi: 10.1002/acr.25652. Epub ahead of print. PMID: 41048053.

Tags: Cedars Sinai DoM, Publications, Rheumatology

Deep learning in fetal, infant, and toddler neuroimaging research

Chin JH, Wyburd MK, Ayzenberg V, Bayet L, Bilgic B, Chen EM, Chen Y, Dineen Á, Fujita S, Liu J, Jun Y, Camacho MC, Zöllei[...]

AI-CVD-AF: A Novel Atrial Fibrillation Prediction Model Based on Coronary Artery Calcium Scans

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Atlas T, Henschke CI, Yankelevitz DF, Zulueta JJ, Fan[...]

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Friedrich NA, Luu M, Gale R, Chaplin A, Polineni R, Shiang A, Shin D, Freedland SJ, Spiegel B, Ballas LK, Kokorowski P, Daskivich TJ. Are[...]